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Toll-like receptors (TLRs) have been found to be key
elements in pathogen recognition by the host immune
system. Dendritic cells (DCs) are crucial for both innate
immune responses and initiation of acquired immunity.
Here we focus on the potential involvement of TLR li-
gand interaction in DC maturation. TLR2 knockout
mice and mice carrying a TLR4 mutation (C3H/HeJ)
were investigated for DC maturation induced by pepti-
doglycan (PGN), lipopolysaccharide (LPS), or lipotei-
choic acids (LTAs). All stimuli induced maturation of
murine bone marrow-derived DCs in control mice.
TLR22/2 mice lacked maturation upon stimulation with
PGN, as assessed by expression of major histocompati-
bility complex class II, CD86, cytokine, and chemokine
production, fluorescein isothiocyanate-dextran uptake,
and mixed lymphocyte reactions, while being com-
pletely responsive to LPS. A similar lack of maturation
was observed in C3H/HeJ mice upon stimulation with
LPS. DC maturation induced by LTAs from two different
types of bacteria was severely impaired in TLR22/2,
whereas C3H/HeJ mice responded to LTAs in a manner
similar to wild-type mice. We demonstrate that DC mat-
uration is induced by stimuli from Gram-positive micro-
organisms, such as PGN and LTA, with similar efficiency
as by LPS. Finally, we provide evidence that TLR2 and
TLR4 interaction with the appropriate ligand is essen-
tial for bacteria-induced maturation of DCs.
Dendritic cells (DCs)1 are potent antigen-presenting cells
and play a key role during the induction of a specific immune
response toward microbial pathogens (1, 2). DCs that encoun-
ter invading microbes capture bacterial antigens and migrate
to lymphoid organs, where they home to the T cell areas. While
migrating to the lymph nodes, they shift from an endocytic/
phagocytic immature stage to a mature stage of efficient T cell
stimulation (1). This activation stage is named maturation and
is accompanied by drastic morphological and functional
changes. Only mature DCs have high levels of surface expres-
sion of MHC and costimulatory molecules that are essential for
efficient T cell stimulation (2). Besides inducing adaptive im-
mune responses, maturing DCs, as part of the innate immune
system, secrete cytokines and chemokines to recruit immune
cells to the site of infection (2). Maturation of DCs can be
induced by microbial antigens, proinflammatory cytokines (e.g.
TNF-a), and non-microbial stimuli such as CD40 ligand (3, 4).
Lipopolysaccharide (LPS), the major immunostimulatory cell
wall component of Gram-negative bacteria, lipoteichoic acid
(LTA) of Gram-positive bacteria, and bacterial peptidoglycan
(PGN) stimulate immune competent host cells to release a
multitude of mediators (5). Circulating LPS and other bacterial
products are recognized by LPS-binding protein and trans-
ported to mCD14. Soluble CD14 enables CD14-negative cells to
respond to LPS challenge (6–8).
Evidence from studies with C3H/HeJ LPS-hyporesponsive
mice and in vitro experiments have led to the discovery that
Toll-like receptors (TLRs) act as the signal-transducing core-
ceptors for recognition of pathogenic microorganisms (9–12).
Several human homologues of the Drosophila Toll have been
identified and termed “Toll-like receptors” (13). The character-
ization of TLR2- and TLR4-deficient mice demonstrated that
TLR4 is involved in the recognition of LPS and LTA (14). TLR2
is involved in the response to PGN of Gram-positive bacteria
and to lipopeptides from several microorganisms including spi-
rochetes, mycobacteria, mycoplasma, whole bacteria, and yeast
(reviewed in Ref. 15).
Recently, it was shown that human DCs express TLR1–5
(16). The expression pattern of TLRs on murine DCs has not
been described yet; however, it is likely that murine DCs ex-
hibit the same expression pattern as human DCs. We focused
on the role of TLR2 and -4 for maturation of DCs. We examined
DCs derived from TLR2-deficient and TLR4-defective C3H/HeJ
mice for their ability to mature after stimulation with Gram-
negative and Gram-positive cell wall components. Our results
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indicate that interaction with the corresponding ligands of
TLRs during bacteria-induced maturation is required for both
the up-regulation of cell surface MHC class II and costimula-
tory molecules on mature DCs. Cytokine secretion of DCs also
depends on TLR integrity, because it is severely impaired in
TLR2-deficient mice upon stimulation with PGN and highly
purified LTA and in C3H/HeJ mice upon stimulation with LPS
and lipid A.
EXPERIMENTAL PROCEDURES
Reagents—LPS from Salmonella minnesota Re 595 was purchased
from Sigma. Synthetic lipid A was kindly provided by L. Hamann,
Borstel Research Center, Borstel, Germany. PGN from Staphylococcus
aureus was provided by Simon J. Foster, Department of Molecular
Biology and Biotechnology, University of Sheffield, Sheffield, UK. LTA
from Bacillus subtilis (DSMZ 1087) and S. aureus (DSMZ 20233) was
extracted using 1-butanol and purified by hydrophobic interaction chro-
matography on octyl-Sepharose as described elsewhere (17, 18). LTA
preparation contained less than 30 pg of LPS per mg of LTA, as
assessed by a chromogenic limulus amebocyte lysate (LAL) assay (Bio
Whittaker, Walkersville, MD). Murine GM-CSF was obtained from
supernatants of NIH3T3 cells stably transfected with mGM-CSF. All
FITC-conjugated antibodies were obtained from PharMingen (Heidel-
FIG. 1. Expression of costimulatory molecules and of MHC
class II molecules in DCs derived from TLR22/2 mice upon stim-
ulation with PGN. DCs from TLR22/2 and wild-type littermates were
cultured in the presence of 10 mg/ml PGN (A) or 10 ng/ml S. minnesota
Re 595 LPS (B) for 24 h. MHC class II (I-Ab) and CD86 expression were
analyzed by FACScan. Unstimulated DCs (thin lines) were compared
with PGN and LPS-stimulated DCs (bold lines). Data shown are rep-
resentative of three separate experiments with identical results.
FIG. 2. Expression of cytokines and chemokines in TLR22/2
DCs upon stimulation with PGN. Bone marrow-derived immature
DCs from TLR22/2 and wild-type littermates were cultured with the
indicated concentrations of PGN for 4 (TNF-a) and 24 h (all others),
respectively. Concentrations of IL-6 (A), TNF-a (B), IL-12p40 (C), and
MIP-2 (D) in the culture supernatant were measured by ELISA. Mean
values 6 S.D. of four independent experiments (A, C, and D) or of two
experiments (B) are shown. Statistical significance was determined by
the Mann-Whitney-U test. p , 0.05 is indicated by asterisks.
FIG. 3. FITC-dextran uptake of DCs derived from TLR22/2
mice. DCs from TLR22/2 mice were cultured with the indicated con-
centrations of PGN and LPS for 24 h. FITC-dextran uptake at 37 °C
(bold lines) was assayed as described under “Experimental Procedures”
and analyzed by flow cytometry. FITC-dextran uptake at 4 °C served as
negative control (thin lines). Data shown are representative of two
separate experiments with identical results.
TABLE I
PGN induces the up-regulation of CD86 and MHC class II in a dose-
dependent manner during DC maturation
DCs were cultured in the presence of the indicated concentration of
PGN for 24 h. MHC class II (I-Ab) and CD86 expression was analyzed
by FACScan. Shown is the mean fluorescence intensity. Data represent
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berg, Germany). FITC-dextran (40,000 kDa) was purchased from Mo-
lecular Probes (Go¨ttingen, Germany).
Animals—C3H/HeJ and C3H/HeN mice were purchased from
Charles River Germany (Sulzfeld, Germany). TLR2 knockout mice were
generated by homologous recombination by Deltagen (Menlo Park, CA)
and kindly provided by Tularik Inc. (South San Francisco, CA). Het-
erozygous mice were backcrossed on C57BL/6 for several generations
before interbreeding yielded TLR2-deficient mice. Age- and sex-
matched TLR2-deficient mice and their heterozygous and wild-type
littermates from these intercrosses were used for DC generation.
Bone Marrow-derived Murine DCs—DCs were isolated from murine
bone marrow according to a modified version of a protocol previously
described (19). Briefly, bone marrow cells were flushed from femurs and
tibias of mice by complete medium (RPMI 1640, 2 mM L-glutamine, 10%
fetal calf serum, 50 mM 2-mercaptoethanol, 100 units/ml penicillin, 100
mg/ml streptomycin). After 24 h of incubation of the obtained cells with
FIG. 4. Antigen-presenting function
of DCs derived from TLR22/2 mice in
an MLR. DCs from TLR22/2 (A) and
wild-type mice (B) were cultured with ei-
ther 5 mg/ml PGN or 10 ng/ml LPS for
24 h. Purified CD41 T cells were added to
the DCs at a DC:T cell ratio of 1:50 and
cultured for an additional 3 days. Concen-
trations of IL-2 in the culture superna-
tants were measured by ELISA. Data
shown represent the mean value of tripli-
cate measurements with S.D. from one
experiment representative of two sepa-
rate experiments with similar results.
FIG. 5. Expression of MHC class II
molecules in C3H/HeJ and C3H/HeN
DCs upon LPS and lipid A stimula-
tion. DCs from C3H/HeJ and C3H/HeN
mice were cultured in the presence of 10
ng/ml S. minnesota Re 595 LPS (A) or 4
ng/ml synthetic lipid A (B) for 24 h. MHC
class II (I-Ek) expression was analyzed by
FACScan. Unstimulated DCs (thin lines)
were compared with LPS and lipid
A-stimulated DCs (bold lines). Data
shown are representative of three sepa-
rate experiments with identical results.
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mGM-CSF-containing (30 ng/ml) complete medium, non-adherent cells
were discarded, and the remaining cells were fed with mGM-CSF-
containing complete medium. This step was repeated on day 3 of incu-
bation. On day 5 of culture, cells were fed with mGM-CSF-containing
medium, and non-adherent cells were used for experiments on day 6
when they were positive for CD11c.
Stimulation of DCs—Bone marrow-derived DCs were washed with
PBS and resuspended in medium plus 5% fetal calf serum. Stimulations
were performed with 200,000 cells/ml or as indicated with PGN (0.1–10
mg/ml), LPS (0.1–100 ng/ml), LTA(10 mg/ml), and synthetic lipid A
(0.4–4 ng/ml) for 24 h as indicated. After 4 and 24 h of stimulation
supernatants were harvested for cytokine analysis, and cells were pro-
cessed for flow cytometry.
Flow Cytometric Analysis—Cells were pre-blocked using rat anti-
mouse CD32 F(ab9)2 antibody (PharMingen) at 5 mg/ml in PBS plus 2%
rat serum at room temperature for 30 min. Next, cells were washed once
in PBS and incubated with rat anti-mouse I-Ab-FITC or I-Ek-FITC,
CD86-FITC, and CD11c-FITC. Finally, cells were fixed in 1% paraform-
aldehyde/PBS and analyzed by FACScan (Becton Dickinson, Heidel-
berg, Germany) using CellQuest software (Becton Dickinson).
Analysis of Endocytosis—To assess endocytosis of the DC prepara-
tions, FITC-dextran was used according to the method described pre-
viously (20). Briefly, cells were incubated in complete medium with
FITC-dextran at a final concentration of 1 mg/ml at 37 °C for 30 min.
Background staining at 4 °C was used as reference. After washing the
cells four times with ice-cold PBS, we analyzed DCs by FACScan,
measuring FITC-dextran uptake of immature DCs.
Quantification of Cytokine Production of Murine Dendritic Cells—
ELISA plates were coated with anti-murine TNF-a antibody (PharM-
ingen). Samples and recombinant murine TNF-a (R & D Systems,
Wiesbaden-Nordenstadt, Germany) were detected using a biotin-la-
beled monoclonal anti-murine TNF-a antibody (PharMingen). For
quantification of IL-6, plates were coated with anti-murine IL-6 anti-
body (PharMingen). Samples and recombinant murine IL-6 (BioCon-
cept) were detected using a biotin-labeled monoclonal anti-murine IL-6
antibody (PharMingen). The detection limits for TNF-a and IL-6 were
31 and 16 pg/ml, respectively. MIP-2, IL-2, and IL-12p40 were meas-
ured by ELISA according to the manufacturer’s instructions (R & D
Systems for MIP-2 and PharMingen for IL-2 and IL-12p40).
Mixed Lymphocyte Reaction (MLR)—Spleens from BALB/c mice were
homogenized to obtain single cell suspensions, and Ficoll was overlaid
with this suspension (Biochrom, Berlin, Germany). Mononuclear cells
obtained from the interphase were washed twice with PBS. Allogeneic
CD41 T cells were isolated employing CD4 microbeads (Milteny Bio-
tech, Bergisch-Gladbach, Germany) and an Auto-Macs separation sys-
tem (Milteny Biotech). Purity of the CD41 T cells was greater than 80%
as assessed by flow cytometric staining for CD3. Bone marrow-derived
DCs from C3H/HeJ and TLR22/2 and corresponding wild-type mice
were stimulated with 10 ng/ml LPS and 5 mg/ml PGN for 24 h. DCs were
mixed with 5 3 104 CD41 T cells at a ratio of 1:50 to assess their T cell
stimulatory capacity. After 3 days of coculture, supernatants were
taken and immediately examined for IL-2 secretion.
Statistics—Data are presented as means 6 S.D. Statistical differ-
ences were determined by the Mann-Whitney-U test. p , 0.05 is con-
sidered significant and is indicated by asterisks.
RESULTS
PGN Induces the Maturation of Bone Marrow-derived Mu-
rine DCs in a Dose-dependent Manner—We investigated
whether PGN of Gram-positive bacteria is able to induce the
maturation of bone marrow-derived murine DCs. Stimulation
of murine DCs with 0.1, 1, and 10 mg/ml PGN for 24 h resulted
in a dose-dependent up-regulation of the costimulatory mole-
cule CD86 and MHC class II molecules and thereby maturation
of DCs (Table I).
Expression of Costimulatory Molecules and MHC Class II
Molecules Is Impaired in TLR2-deficient Mice upon Stimula-
tion with PGN—To assess whether PGN-induced maturation of
DCs is initiated via TLR2, we examined the responsiveness of
DCs from TLR2-deficient mice to PGN and, as control, to LPS.
First, we examined the expression of MHC class II molecules
and CD86 on DCs from TLR2-deficient and control mice by flow
cytometry. PGN induced an increase in the expression of MHC
class II molecules on wild-type DCs (Fig. 1A). In contrast,
induction of MHC class II and CD86 by PGN was impaired in
TLR22/2 DCs. TLR2 heterozygous littermates exhibited an
intermediate response (data not shown). Expression of CD86
and MHC class II in response to LPS was up-regulated in
TLR2-deficient and wild-type mice (Fig. 1B).
Expression of Proinflammatory Cytokines, TH1 Cytokines,
and Chemokines Is Impaired in DCs Derived from TLR2-defi-
cient Mice upon Stimulation with PGN—Next, the production
of IL-6, TNF-a, IL-12p40, and MIP-2 by DCs upon stimulation
with increasing concentrations of PGN was determined (Fig. 2).
Whereas stimulation of wild-type DCs with PGN resulted in a
dose-dependent response for all cytokines, stimulation of
TLR2-deficient mice led to an impaired response for IL-6, IL-
12, and MIP-2 and no response at all for TNF-a. Production of
IL-6, TNF-a, MIP-2, and IL-12p40 in response to stimulation
with LPS, in contrast, was strongly induced in DCs from TLR2-
deficient mice, as expected (data not shown).
Antigen Uptake of Immature Dendritic Cells Derived from
TLR22/2 Mice—To confirm the observed lack of DC matura-
tion in TLR22/2 mice stimulated with PGN by a functional
assay, we tested the capacity of antigen capture by DCs as
measured by FITC-dextran uptake. For this purpose DCs were
incubated with FITC-dextran at 4 and 37 °C (Fig. 3). Unstimu-
FIG. 6. Expression of cytokines and chemokines in DCs de-
rived from C3H/HeJ and C3H/HeN mice upon stimulation with
lipid A. DCs from C3H/HeJ and C3H/HeN mice were cultured with the
indicated concentrations of lipid A for 24 h. Concentrations of IL-6 (A),
IL-12p40 (B), and MIP-2 (C) in the culture supernatants were measured
by ELISA. Mean values 6 S.D. of two independent experiments are
shown. n.d., not detectable.
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lated immature DCs derived from TLR22/2 mice displayed an
uptake of FITC-dextran at 37 °C, which was completely lost
upon maturation induced by LPS. TLR22/2 DCs stimulated
with PGN displayed an FITC-dextran uptake similar to that of
the control DCs, indicating that these cells are functionally still
immature.
Antigen Presentation of Mature Dendritic Cells Derived from
TLR22/2 Mice in MLRs—To further examine the functional
consequences of TLR2 deficiency, we investigated the capacity
of DCs derived from TLR22/2 mice stimulated with PGN and
LPS to stimulate T cells in an allogeneic MLR (Fig. 4). Unstim-
ulated DCs and PGN- and LPS-stimulated DCs derived from
TLR22/2 and TLR21/1 mice were cocultured with allogeneic
T cells at a DC:T cell ratio of 1:50 for 3 days. T cell activation was
assessed by IL-2 release. Because IL-2 is not produced by DCs,
activated T cells in the cocultures are the only source of IL-2.
FIG. 7. Antigen-presenting function
of DCs derived from C3H/HeJ and
C3H/HeN mice in an MLR. DCs from
C3H/HeJ (A) and C3H/HeN mice (B) were
cultured with either 5 mg/ml PGN or 10
ng/ml LPS for 24 h. Purified CD41 T cells
were added to the DCs at a DC:T cell ratio
of 1:50 and cultured for an additional 3
days. Concentrations of IL-2 in the cul-
ture supernatants were measured by
ELISA. Data shown represent the mean
value of triplicate measurements with
S.D. from one experiment representative
of two separate experiments with similar
results.
FIG. 8. Expression of costimulatory
molecules in TLR22/2 and C3H/HeJ
DCs upon LTA stimulation. DCs from
TLR22/2, TLR21/1, C3H/HeJ, and C3H/
HeN mice were cultured in the presence
of 10 mg/ml S. aureus or B. subtilis LTA
for 24 h. CD86 expression of DCs from
deficient mice (A) or corresponding wild-
type mice (B) were analyzed by FACScan.
Unstimulated DCs (thin lines) were com-
pared with LTA-stimulated DCs (bold
lines).
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DCs derived from TLR22/2 mice stimulated with PGN were not
able to induce IL-2 secretion from T cells similar to untreated
cells (Fig. 4A), whereas DCs from TLR21/1 mice stimulated
with PGN induced substantial IL-2 secretion of T cells (Fig.
4B). In contrast, DCs from TLR22/2 and TLR21/1 mice were
both found to be effective inducers of IL-2 secretion when
stimulated with LPS, as expected.
Expression of MHC Class II Is Impaired in C3H/HeJ Mice
upon Stimulation with LPS and Lipid A—To determine the
role of TLR4 in DC maturation, we examined the maturation of
DCs from C3H/HeJ and C3H/HeN mice upon stimulation with
LPS. Stimulation of DCs of C3H/HeN mice with LPS resulted
in an up-regulation of MHC class II molecules. In contrast, LPS
stimulation of DCs derived from C3H/HeJ mice led to an im-
paired up-regulation of MHC class II molecules (Fig. 5A). Sim-
ilar results were obtained using a synthetic lipid A preparation
(Fig. 5B). Additionally, FITC-dextran uptake in C3H/HeJ mice
stimulated with LPS confirmed the lack of maturation of DCs
in C3H/HeJ mice (data not shown).
Expression of Proinflammatory Cytokines, TH1 Cytokines,
and Chemokines Is Impaired in C3H/HeJ Mice upon Stimula-
tion with Lipid A—We next examined the cytokine secretion of
DCs during maturation upon stimulation with lipid A, the
bioactive component of LPS. Whereas stimulation with lipid A
resulted in a response in DCs from C3H/HeN mice, in C3H/HeJ
mice no IL-6 (Fig. 6A), IL-12 (Fig. 6B), and MIP-2 (Fig. 6C)
response upon lipid A stimulation could be observed. Addi-
tional experiments with LPS led to a similar lack of cytokine
and chemokine response in DCs from C3H/HeJ mice (data not
shown).
Antigen Presentation of Mature Dendritic Cells Derived from
C3H/HeJ and C3H/HeN Mice in MLRs—We also investigated
the capacity of C3H/HeJ- and C3H/HeN-derived DCs stimu-
lated with PGN and LPS to induce IL-2 production of allogeneic
T cells (Fig. 7). LPS-stimulated DCs derived from C3H/HeJ
mice were unable to increase IL-2 release from T cells as
compared with untreated cells (Fig. 7A). DCs from C3H/HeN
mice, in contrast, enhanced the IL-2 production of T cells after
stimulation with LPS (Fig. 7B). DCs from both mice strains
were effective in inducing IL-2 secretion when stimulated with
the TLR2 ligand PGN, as expected.
Expression of Cytokines and CD86 in C3H/HeJ Mice upon
Stimulation with LTA—To assess LTA-induced maturation of
DCs, we examined the responsiveness of DCs from TLR2- and
TLR4-deficient mice to LTA from S. aureus and B. subtilis.
Stimulation of DCs derived from C3H/HeJ and C3H/HeN mice
with highly purified LTA from S. aureus and B. subtilis re-
sulted in the up-regulation of CD86 in both strains (Fig. 8, A
and B, left panels). Furthermore, no differences in secretion of
IL-6 (Fig. 9A) in LTA-induced DC maturation could be observed
in either mouse strain. In contrast, up-regulation of CD86 in
DCs from TLR2-deficient mice was severely impaired upon
LTA stimulation compared with wild-type mice (Fig. 8, A and
B, right panels). Additionally, production of IL-6 (Fig. 9B) was
not detectable in DCs from TLR2-deficient mice in response to
LTA from S. aureus and B. subtilis. Similar results have been
obtained for the production of IL-12 upon LTA stimulation
(data not shown).
DISCUSSION
Dendritic cells are antigen-presenting cells with the unique
ability to initiate both innate immune responses and a highly
specific acquired immunity (1). Therefore, these cells have been
the focus of intensive investigations in biomedical research, i.e.
in the area of cancer research for developing DC-based cancer
vaccines as a novel immunotherapy. DCs activate both naı¨ve
and memory CD41 and CD81 T cells and seem to meet all
requirements as a strong vaccine for antitumor immunity or
immunity against microbial infection (21). Located in most host
tissues, DCs function as mobile sentinels for infectious agents
and inflammatory products of bacteria. In contrast to macro-
phages, the phagocytosis of bacteria by DCs is limited (3). After
challenge with bacteria, DCs enter the process of maturation
and migrate to lymphoid organs. During this process DCs not
only lose the ability of phagocytosis, but they also produce large
amounts of cytokines and chemokines (3). Simultaneously,
MHC class II molecules are translocated to the membrane, and
costimulatory molecules such as CD86 and CD40 are up-regu-
lated (1, 22).
Because of the important role of DCs as a mediator between
innate and adaptive immunity, it is of great importance to
elucidate the regulation of their maturation and to analyze the
molecules involved. Here we show the involvement of TLR2
and TLR4 in the maturation of DCs. Both TLR2 and TLR4 have
been implicated in the recognition of bacterial cell wall prod-
ucts of Gram-positive (14, 23, 24) and Gram-negative bacteria
(9, 25), spirochetes (26), yeast (23), and mycobacteria (23, 27)
by the innate immune system. Although certain bacterial stim-
uli are well known as inducers of DC maturation, the receptor
mechanism involved in this induction of maturation has not yet
been elucidated. Besides induction by bacterial stimuli, DC
maturation can also be induced by proinflammatory cytokines
(TNF-a) and CD40 cross-linking by CD40 ligand on activated T
cells. A very recent report, however, notes that for CD40-in-
duced IL-12 production of murine DCs additional microbial
stimuli are required for obtaining an optimal response (28).
Our findings of the involvement of TLRs in bacteria-induced
DC maturation complement theories on bridging innate and
acquired immunity by pattern recognition receptors such as the
TLRs (29).
Common understanding defines DCs as cells lacking
FIG. 9. Expression of IL-6 in TLR22/2 and C3H/HeJ DCs upon
stimulation with LTA. DCs (4 3 105 cells/ml) from TLR22/2,
TLR21/1, C3H/HeJ, and C3H/HeN mice were cultured in the presence
of 10 mg/ml S. aureus or B. subtilis LTA, 100 ng/ml S. minnesota Re 595
LPS (A), or 10 mg/ml PGN (B) for 24 h. Concentrations of IL-6 in the
culture supernatant were measured by ELISA. Mean values 6 S.D. of
two independent experiments are shown. n.d., not detectable.
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mCD14. By employing blocking CD14 antibodies, it was dem-
onstrated that LPS-induced responses of human DCs are de-
pendent on soluble CD14 (30). Utilizing murine CD14 antibod-
ies a down-regulation of the LPS-induced response of DCs was
also detected (31). Our present study provides substantial ev-
idence that bacteria-induced maturation of DCs depends on
TLR interaction; PGN-induced maturation of DCs is severely
impaired in TLR22/2 mice. LPS- and lipid A-induced DC mat-
uration is initiated via TLR4 occupation, because DCs from
C3H/HeJ mice were unable to undergo maturation. Lack of
TLR2 or -4 abolished up-regulation of MHC class II and CD86
and led to an impaired secretion of proinflammatory cytokines,
chemokines, and TH1 cytokines upon stimulation with the ap-
propriate ligand. To address the biological relevance of these
findings we employed two different functional assays for DC
maturation. Antigen presentation was found to be severely
impaired in TLR22/2 and C3H/HeJ DCs when stimulated with
the appropriate ligand, as measured by IL-2 secretion of cocul-
tured T cells. In addition, FITC-dextran antigen uptake, a
characteristic function of immature DCs, could not be down-
regulated by the maturation-inducing ligands PGN or LPS in
DCs derived from TLR2- and TLR4-deficient mice. These find-
ings led us to conclude that DCs deficient in TLR2 or TLR4 do
not undergo maturation upon stimulation with the TLR2 li-
gand PGN and the TLR4 ligands LPS and lipid A, respectively.
The question whether LTA signals via TLR2 or -4 has been
controversial (14, 32, 33). Schwandner et al. (32) demonstrated
that HEK293 cells overexpressing TLR2 regained the ability to
react upon LTA stimulation with NF-kB translocation. This
HEK293 system has been questioned recently in the context of
LPS-induced signal transduction due to a lack of expression of
MD-2, a molecule associated with TLR4 and absolutely re-
quired for LPS signaling via TLR4 (34). In the context of
TLR2-mediated signal transduction, however, this system still
may be valuable.2 In contrast, it was recently reported that
TLR42/2 macrophages, but not wild-type or TLR22/2 macro-
phages, failed to respond to LTA from S. aureus (14). Our
results presented here clearly demonstrate that DCs derived
from C3H/HeJ mice respond to LTA from B. subtilis and S.
aureus to a similar extent as DCs from C3H/HeN mice regard-
ing their secretion of cytokines as well as up-regulation of
CD86. The results obtained with DCs from TLR22/2 mice fur-
thermore support the view that TLR2 is the signal transducer
for LTA. These discrepancies between our data and the report
mentioned above may be due to differences in the cell type
employed (DCs versus macrophages) or to differences in the
purification procedure applied for the LTA used. We observed a
slightly higher expression of IL-6 (Fig. 9A) and IL-12 (data not
shown) in DCs derived from C3H/HeJ mice compared with
C3H/HeN mice when stimulated with highly purified LTA from
S. aureus as well as B. subtilis. An up-regulation of TLR2 or
other TLRs to compensate for the loss of TLR4 may be an
explanation for this phenomenon.
In summary, our results demonstrate that recognition of cell
wall compounds of Gram-positive and Gram-negative bacteria
by TLRs on the surface of DCs is essential for bacteria-induced
DC maturation and thus for initiation of innate and acquired
immune responses. Gaining further insight into DC matura-
tion may increase understanding of DC biology and of how to
utilize these cells in clinical applications.
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